Stay updated with breaking news from Michael Klichinsky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma"), a clinical stage biopharmaceutical company focused on discovering and developing...
PHILADELPHIA, April 6, 2023 /PRNewswire/ -- Carisma Therapeutics Inc. , a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced... | April 6, 2023
/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM), a clinical stage biopharmaceutical company focused on discovering and developing innovative...
Carisma Therapeutics, Inc. (NASDAQ:CARM – Get Rating)’s share price traded up 0.3% during trading on Friday . The stock traded as high as $3.20 and last traded at $3.10. 40,007 shares were traded during mid-day trading, a decline of 56% from the average session volume of 90,607 shares. The stock had previously closed at $3.09. […]
19.01.2023 - Sesen Bio, Inc. (Nasdaq: SESN) today announced that it has filed definitive proxy materials with the U.S. Securities and Exchange Commission in connection with the Company’s pending merger with Carisma Therapeutics Inc. (Carisma), a privately held, ...